Skip to main content
. 2023 Feb 10;8:63. doi: 10.1038/s41392-023-01316-8

Fig. 1.

Fig. 1

YTHDF2 O-GlcNAcylation is enhanced upon HBV infection. a Immunoblots quantitative analysis of YTHDF2 expression in HBV-associated HCC tumors (n = 48), P < 0.001. b Analysis of YTHDF2 O-GlcNAcylation in HBV-associated HCC tumors (n = 42) by succinylated wheat germ agglutinin (sWGA) pull-down assays. YTHDF2 O-GlcNAcylation levels were quantified, P < 0.01. c Analysis of YTHDF2 O-GlcNAcylation in HBV-transgenic mice (n = 4), normal C57 mice were used as control. dg YTHDF2 Immunoprecipitation (IP) with anti-Flag M2 agarose beads in hepatoma cells transfected with Flag-YTHDF2 or a vector control. Specifically, HepAD38 cells were cultured without tetracycline (tet) (d), HepG2-NTCP cells were infected with HBV viruses (e), HepG2 cells (f) and Huh7 cells (g) were infected with AdHBV1.3 (named as HepG2-HBV1.3 and Huh7-HBV1.3) and treated with 25 μΜ Thiamet G (TMG) for 12 h. hk sWGA pull-down assays were performed in HepG2-NTCP cells infected with HBV viruses (h), HepG2-HBV1.3 cells (i, j) and Huh7-HBV1.3 cells (k) treated with 25 μΜ TMG or 20 μΜ OSMI-1 for 12 h. Western blotting was determined by anti-YTHDF2. All the presented input was adjusted to a similar level for the following IP or sWGA-binding assay